Effect of the opioid crisis on the liver transplantation donor pool: A national analysis
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15290 ↗At a glance
Journal article in Clinical Transplantation, 2024. Written by Yutaka Endo and 10 co-authors. Institution: Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA. Major MEDLINE topics: Liver Transplantation, Drug Overdose, COVID-19. Cited 1 times so far (Crossref); 32 references.
Abstract (original language)
Background
Over the last decade there has been a surge in overdose deaths due to the opioid crisis. We sought to characterize the temporal change in overdose donor (OD) use in liver transplantation (LT), as well as associated post‐LT outcomes, relative to the COVID‐19 era.
Methods
LT candidates and donors listed between January 2016 and September 2022 were identified from the Scientific Registry of Transplant Recipients database. Trends in LT donors and changes related to OD were assessed pre‐ versus post‐COVID‐19 (February 2020).
Results
Between 2016 and 2022, most counties in the United States experienced an increase in overdose‐related deaths ( n = 1284, 92.3%) with many counties ( n = 458, 32.9%) having more than a doubling in drug overdose deaths. Concurrently, there was an 11.2% increase in overall donors, including a 41.7% increase in the number of donors who died from drug overdose. In pre‐COVID‐19 overdose was the 4th top mechanism of donor death, while in the post‐COVID‐19 era, overdose was the 2nd most common cause of donor death. OD was younger (OD: 35 yrs, IQR 29–43 vs. non‐OD: 43 yrs, IQR 31–56), had lower body mass index (≥35 kg/cm 2 , OD: 31.2% vs. non‐OD: 33.5%), and was more likely to be HCV+ (OD: 28.9% vs. non‐OD: 5.4%) with lower total bilirubin (≥1.1 mg/dL, OD: 12.9% vs. non‐OD: 20.1%) (all p < .001). Receipt of an OD was not associated with worse graft survival (HR .94, 95% CI .88–1.01, p = .09).
Conclusions
Opioid deaths markedly increased following the COVID‐19 pandemic, substantially altering the LT donor pool in the United States.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA.
- Department of Surgery, Stanford University, Stanford, California, USA.
ORCID profiles: Ashley Limkemann, Timothy M Pawlik
Cite
APA
Endo, Y., Sasaki, K., Munir, M. M., Woldesenbet, S., Tsilimigras, D. I., Katayama, E., Yang, J., Limkemann, A., Schenk, A., Washburn, K., & Pawlik, T. M. (2024). Effect of the opioid crisis on the liver transplantation donor pool: A national analysis. Clinical Transplantation. https://doi.org/10.1111/ctr.15290
Vancouver
Endo Y, Sasaki K, Munir MM, Woldesenbet S, Tsilimigras DI, Katayama E, et al. Effect of the opioid crisis on the liver transplantation donor pool: A national analysis. Clinical Transplantation. 2024. doi:10.1111/ctr.15290
BibTeX
@article{Endo2024,
author = {Endo, Yutaka and Sasaki, Kazunari and Munir, Muhammad Musaab and Woldesenbet, Selamawit and Tsilimigras, Diamantis I and Katayama, Erryk and Yang, Jason and Limkemann, Ashley and Schenk, Austin and Washburn, Kenneth and Pawlik, Timothy M},
title = {Effect of the opioid crisis on the liver transplantation donor pool: A national analysis},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15290}
}
EUVIMED